Risikoen blev mindsket med 41% i løbet af tre år, idet 21% af de 719 kvinder, der tog PROTELOS, fik nye brud på rygsøjlen, sammenholdt med 33% af de 723, der fik placebo.
The risk was reduced by 41% over three years, with 21% of the 719 women who took PROTELOS developing a new vertebral fracture, compared with 33% of those 723 who took placebo.